Pricing

InflaRx

0 followers

‌

InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.

Industries

Biotechnology

Headquarters

Jena, Germany

Employees

11-50

Links

Org chart

Niels C. Riedemann

CEO & Founder

Niels C. Riedemann

Collapse

Renfeng Guo

Chief Scientific Officer & Founder

Thomas Taapken

Chief Financial Officer

Camilla Chong

Chief Medical Officer

Nicole Bertsch

Senior Director, Head of Human Resources

Jacky Schmitt

Senior Director Manufacturing, ext.

Daniel Vetter

Senior Director, Head of IT

Wantanee Phuapradi

Senior Director, Small Molecule Drug Product Development & CMC

Timothy E. Hermes

VP, Commercial

Michelle Medovich

Head Of Marketing

Teams

Research & Development

7 members

Medical and Scientific Affairs

5 members

Human Resources and Administrative

4 members

Leadership Team

3 members

Finance and Commercial

3 members

Similar companies

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Artiva Biotherapeutics

1 follower

Thermo Fisher Scientific

158 followers

CRISPR Therapeutics

9 followers

Adverum Biotech

8 followers

Legend Biotech

5 followers

Roche

238 followers

Loam Bio

3 followers

Verve Therapeutics

54 followers

ImmunityBio

2 followers

Explore companies